Manufacturers OEM

TNR Diagnostics Pte Ltd

#05-05/06, 79 Ayer Rajah Crescent , 139955 Singapore
Singapore

Telephone +65 63975155
Fax +65 63975055
theotan@thebiofactory.com

This company is co-exhibitor of
Singapore Manufacturing Federation

Trade fair hall

  • Hall 16 / F57
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 16): stand F57

Fairground map

MEDICA 2016 fairground map: Hall 16

Contact

Theodore Tan

http://www.tnrdiagnostics.com
139955 singapore, Singapore

Phone
+65 63975155

Fax
+65 63975055

Email
sales@thebiofactory.com

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.02  DNA diagnosis kits

Our products

Product category: DNA diagnosis kits

FastFraX™ FMR1

The FastFraX™ FMR1 Identification Kit is a quick and robust first-line test to distinguish between Non-Expanded* and Expanded FMR1 alleles in Fragile X Syndrome. This substantially reduces the number of samples for confirmatory testing.

Key features:

• First-line screening test
• Minimal handling time
• Simple data interpretation

Screening test for:

• Sperm/Egg donor status (in-vitro fertilisation)
• Newborn screening
• Primary ovarian insufficiency (POI)
• Premutation carrier status
• Individuals with intellectual disability

* Classification depends on selection of cut-off control

More Less

Product category: DNA diagnosis kits

FastDM1™ DMPK Identification Kit

The FastDM1™ DMPK Identification Kit is a quick and robust first-line test to distinguish between Non-Expanded and Expanded DMPK alleles in Myotonic Dystrophy Type 1.

Key features:

• First-line screening test
• Minimal handling time
• Simple data interpretation

Screening test for:

• Predictive testing
• Carrier status
• Sperm/Egg donor status (in-vitro fertilisation)
• Newborn screening

More Less

Product category: DNA diagnosis kits

FastFraX™ FMR1 Identification Kit

The FastFraX™ FMR1 Identification Kit is a quick and robust first-line test to distinguish between Non-Expanded* and Expanded FMR1 alleles in Fragile X Syndrome. This substantially reduces the number of samples for confirmatory testing.

Key features:

• First-line screening test
• Minimal handling time
• Simple data interpretation

Screening test for:

• Sperm/Egg donor status (in-vitro fertilisation)
• Newborn screening
• Primary ovarian insufficiency (POI)
• Premutation carrier status
• Individuals with intellectual disability
* Classification depends on selection of cut-off control

More Less

About us

Company details

TNR Diagnostics is a life sciences start-up which is focused on providing accurate and user-friendly in vitro tests for the rapid screening and characterization of genetic repeat disorders. The tests are based on innovative diagnostic solutions developed at the National University of Singapore (NUS). As an incubatee of The Biofactory, TNR Diagnostics was able to accelerate the development and launch of these novel in-vitro diagnostic kits.

TNR Diagnostics is currently developing FastFraX IVD kits for first-line screening and diagnosis of Fragile X Syndrome. The company is also exploring solutions for the screening and diagnosis of other genetic repeat disorders such as Huntington’s Disease and Myotonic Dystrophy Type 1.

More Less

Company data

Sales volume

< 1 Mio US $

Export content

max. 75%

Number of employees

1-19

Foundation

2014

Area of business

Diagnostics